David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.31% |
| 2 | Healthcare | 10.66% |
| 3 | Consumer Discretionary | 10.29% |
| 4 | Communication Services | 8.78% |
| 5 | Financials | 8.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Pentair
PNR
$10B
| $2.92M | ﹤0.01% |
63,941
-72,816
| -53% | -$3.13M |
|
1727
PUT
Capri Holdings
CPRI
$1.55B
| $2.91M | ﹤0.01% |
60,900
| – | – |
|
1728
Advanced Energy
AEIS
$11.3B
| $2.91M | ﹤0.01% |
35,997
-2,313
| -6% | -$168K |
|
|
NBL
1729
PUT
DELISTED
Noble Energy, Inc.
NBL
| $2.9M | ﹤0.01% |
102,300
+53,200
| +108% | +$1.4M |
|
1730
Sanmina
SANM
$10.6B
| $2.9M | ﹤0.01% |
78,049
-128,286
| -62% | -$4.79M |
|
1731
Axcelis
ACLS
$3.72B
| $2.9M | ﹤0.01% |
105,954
-24,717
| -19% | -$547K |
|
1732
MetLife
MET
$61.3B
| $2.9M | ﹤0.01% |
55,734
+38,563
| +225% | +$1.88M |
|
|
ORBK
1733
DELISTED
Orbotech Ltd
ORBK
| $2.89M | ﹤0.01% |
68,573
-5,402
| -7% | -$206K |
|
1734
Donnelley Financial Solutions
DFIN
$1.17B
| $2.89M | ﹤0.01% |
134,151
-66,854
| -33% | -$1.45M |
|
|
CSW
1735
CSW Industrials
CSW
$5.26B
| $2.88M | ﹤0.01% |
64,879
-20,473
| -24% | -$831K |
|
1736
Canadian Natural Resources
CNQ
$102B
| $2.87M | ﹤0.01% |
175,263
+93,124
| +113% | +$1.43M |
|
1737
CALL
Howmet Aerospace
HWM
$107B
| $2.87M | ﹤0.01% |
150,612
| – | – |
|
|
LPNT
1738
DELISTED
LifePoint Health, Inc.
LPNT
| $2.87M | ﹤0.01% |
+49,531
| New | +$2.95M |
|
|
SRDX
1739
DELISTED
Surmodics
SRDX
| $2.87M | ﹤0.01% |
92,466
+9,887
| +12% | +$269K |
|
1740
Cohu
COHU
$2.42B
| $2.86M | ﹤0.01% |
119,938
+41,045
| +52% | +$776K |
|
|
SHOE
1741
Shoe Station Group
SHOE
$391M
| $2.85M | ﹤0.01% |
254,804
+233,750
| +1,110% | +$2.17M |
|
1742
Marcus Corp
MCS
$913M
| $2.85M | ﹤0.01% |
102,716
+34,169
| +50% | +$917K |
|
1743
CALL
Occidental Petroleum
OXY
$58.6B
| $2.85M | ﹤0.01% |
44,300
| – | – |
|
|
GRP.U
1744
DELISTED
Granite Real Estate Investment Trust
GRP.U
| $2.84M | ﹤0.01% |
70,668
-2,400
| -3% | -$96.7K |
|
1745
Orthofix Medical
OFIX
$397M
| $2.83M | ﹤0.01% |
59,998
-15,345
| -20% | -$723K |
|
1746
Belden
BDC
$4.61B
| $2.8M | ﹤0.01% |
34,738
+6,591
| +23% | +$498K |
|
|
ZAGG
1747
DELISTED
ZAGG Inc Common Stock (Delaware)
ZAGG
| $2.8M | ﹤0.01% |
177,515
+46,982
| +36% | +$515K |
|
1748
UFP Industries
UFPI
$4.76B
| $2.79M | ﹤0.01% |
85,392
-789
| -0.9% | -$22.8K |
|
1749
Match Group
MTCH
$9.66B
| $2.79M | ﹤0.01% |
120,343
+95,431
| +383% | +$1.92M |
|
1750
CALL
Veeva Systems
VEEV
$39.8B
| $2.79M | ﹤0.01% |
49,400
| – | – |
|
Similar funds
David Shaw's Q3 2017 Portfolio in Review
As of Q3 2017, David Shaw held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
David Shaw's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- David Shaw's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- David Shaw added most to Comcast in Q3 2017, an estimated $354M increase.
- David Shaw's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- David Shaw fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- David Shaw's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- David Shaw opened 469 new positions and closed 370 in Q3 2017.
- David Shaw's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.